Translational Pathways for Cardiovascular Devices

Course Directors: Nabil Dib, MD; Spencer King, MD; Anthony DeMaria, MD

This course will fulfill an unmet educational need and provide you with valuable knowledge to be successful in developing therapies and expediting scientific discovery to patients. Ultimately, this course will enable you to contribute to product development to improve survival and the quality of life while decreasing costs. This course will change your approach to medicine and innovation. The information is critical for anyone who works in product development, whether as an innovator, physician, scientist, engineer, regulator, or at a reimbursement agency.

Preview This Free Lecture!

Regulatory Requirement For Marketing Approval – Bram Zuckerman, MD, FDA

The TAVR Development from Concept to First in Man - Alain Cribier, MD, University of Rouen, France

The TAVR development from First in Man to Phase 3 and Beyond - Martin Leon, MD, Columbia University

Regulatory Requirement For Marketing Approval - Bram Zuckerman, MD, FDA

*For more information related to these Topics preview the Sampled Sessions below!

Course Directors: Nabil Dib, MD; Spencer King, MD; Anthony DeMaria, MD

Preview This Free Lecture!

Regulatory Requirement For Marketing Approval – Bram Zuckerman, MD, FDA

The TAVR Development from Concept to First in Man - Alain Cribier, MD, University of Rouen, France

The TAVR development from First in Man to Phase 3 and Beyond - Martin Leon, MD, Columbia University

Regulatory Requirement For Marketing Approval - Bram Zuckerman, MD, FDA

Course Content

Account

Courses

eBooks

Resources